Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping
In February 2025, the National Medical Products Administration (NMPA) approved Innogens ultra-long-acting GLP-1 injection for type 2 diabetes, signaling growing government and regulatory support for GLP-1 innovation and boosting industry confidence
These findings show that GLP-1s are incredibly effective at lowering blood pressure in certain people, according to senior study author Micah Eimer, MD, a cardiologist and a clinical assistant professor of medicine at Northwestern University Feinberg School of Medicine
PMID: 12626323 A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects
US$ 27.60
US$ 20.39
US$ 28.98
US$ 28.57
US$ 21.18
US$ 21.15
